Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases
Pavel Kolkhir, Daniel Elieh Ali Komi, Martin Metz, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 5, pp. 294-308
Closed Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Lactate metabolism in human health and disease
Xiaolu Li, Yanyan Yang, Bei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 594
Urticaria
Pavel Kolkhir, Ana M. Giménez‐Arnau, Kanokvalai Kulthanan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 201
Autoimmune chronic spontaneous urticaria
Pavel Kolkhir, Melba Muñoz, Riccardo Asero, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1819-1831
Closed Access | Times Cited: 153
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 110
Neuroimmune communication regulating pruritus in atopic dermatitis
Martin Steinhoff, Fareed Ahmad, Atul Kumar Pandey, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1875-1898
Open Access | Times Cited: 81
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances
Allen P. Kaplan, Mark Lebwohl, Ana M. Giménez‐Arnau, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 389-401
Open Access | Times Cited: 81
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 62
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 52
Chronic urticaria and the pathogenic role of mast cells
Daniel Elieh Ali Komi, Martin Metz, Pavel Kolkhir, et al.
Allergology International (2023) Vol. 72, Iss. 3, pp. 359-368
Open Access | Times Cited: 40
The Immunology of Psoriasis—Current Concepts in Pathogenesis
Izabela Siemińska, Monika Pieniawska, Tomasz M. Grzywa
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 2, pp. 164-191
Open Access | Times Cited: 36
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 1, pp. 184-194
Open Access | Times Cited: 33
Bienzyme-Locked Activatable Fluorescent Probes for Specific Imaging of Tumor-Associated Mast Cells
Yuxuan Hu, Jie Yu, Mengke Xu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 18, pp. 12656-12663
Closed Access | Times Cited: 30
Gut microbiota facilitate chronic spontaneous urticaria
Lei Zhu, Xingxing Jian, Bingjing Zhou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Intraepithelial mast cells drive gasdermin C-mediated type 2 immunity
Yang Liu, Huabin He, Xue-kun Guo, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1056-1070.e5
Closed Access | Times Cited: 16
Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment
Torsten Zuberbier, Luís Felipe Ensina, Ana M. Giménez‐Arnau, et al.
The Lancet (2024) Vol. 404, Iss. 10450, pp. 393-404
Open Access | Times Cited: 15
KIT as a master regulator of the mast cell lineage
Mindy Tsai, Peter Valent, Stephen J. Galli
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1845-1854
Open Access | Times Cited: 62
Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions
Pedro Mendes‐Bastos, Ana Brasileiro, Pavel Kolkhir, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2355-2366
Open Access | Times Cited: 58
Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study
Diego Alvarado, Marcus Maurer, Richard Gedrich, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2393-2403
Open Access | Times Cited: 50
Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell‐mediated diseases
Martin Metz, Pavel Kolkhir, Sabine Altrichter, et al.
Allergy (2023) Vol. 79, Iss. 1, pp. 37-51
Open Access | Times Cited: 29
Mast Cells as a Target—A Comprehensive Review of Recent Therapeutic Approaches
Joanna Baran, Anna Sobiepanek, Anna Mazurkiewicz-Pisarek, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1187-1187
Open Access | Times Cited: 28
Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment
George Ν. Konstantinou, Marc A. Riedl, Peter Valent, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 94-106
Closed Access | Times Cited: 21
Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy
Fanfan Du, Clayton H. Rische, Yang Li, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 5, pp. 698-704
Open Access | Times Cited: 10
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists
Joshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 4, pp. 1033-1043
Open Access | Times Cited: 10
Cellular and Molecular Mechanisms of Mast Cells in Atherosclerotic Plaque Progression and Destabilization
Daniel Elieh Ali Komi, Ilze Bot, Mónica Rodríguez-González, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 1, pp. 30-49
Open Access | Times Cited: 9
Mast cells: a novel therapeutic avenue for cardiovascular diseases?
Remo Poto, Gianni Marone, Stephen J. Galli, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 681-698
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top